FDG-PET/CT helps determine risk of vascular events in cancer patients

10/11/2009 | AuntMinnie.com (free registration)

A German study on patients who underwent FDG-PET/CT scans for neoplastic disease found that "the combination of a calcified plaque sum greater than 15 and a mean TBR of greater than 1.7 identified patients at highest risk for a future vascular event." The finding suggests that patients undergoing PET/CT tests for cancer diagnosis or staging could also know their atherogenic risk, the researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC